NCCN临床实践指南:老年肿瘤(2025.V1)
指南制定者:美国国家综合癌症网络
出处:NCCN官网
发布时间:2024-12-09
1.指南来源(Guide Source):
NCCN临床实践指南:老年肿瘤 V1.2025.发布已获NCCN肿瘤学临床实践指南(NCCN指南®)许可。©2024美国国家综合癌症网络公司.保留所有权利。未经NCCN明确的书面许可,不得出于任何目的以任何形式复制NCCN指南®和文中的插图。要查看NCCN指南的最新完整版本,请访问NCCN.org。NCCN指南是一项持续进行的工作,可能会随着新的重要数据的出现而不断完善。
2.免责声明(Disclaimers):
NCCN对其内容、使用或应用不做任何形式的担保,并否认以任何方式对其应用或使用承担任何责任。
在下载本篇指南前,请先您详细阅读并同意以下协议:
NCCN内容不得用于商业目的,以及NCCN作为NCCN内容的许可方,不作任何陈述或保证,并明确否认NCCN指南适用于任何特定患者的护理或治疗,任何医院、寻求使用《NCCN指南》治疗患者的临床医生或其他医疗服务提供者(“提供者”)应根据特定患者护理或治疗的具体临床情况做出独立的医疗判断,NCCN不建议、推荐或认可任何提供者(无论是否与被许可方相关)进行任何有偿或无偿的医疗治疗、咨询或服务,也不应因被许可方建议、推荐或认可任何此类提供者的作为或不作为而直接或间接承担责任。详见《NCCN最终用户许可协议》
3.专家名单(Staff):
*Efrat Dotan, MD/Chair † Fox Chase Cancer Center
*Louise C. Walter, MD/Vice Chair ₪ UCSF Helen Diller Family Comprehensive Cancer Center
Ryan Beechinor, PharmD, BCOP ‡ Σ UC Davis Comprehensive Cancer Center
Ilene S. Browner, MD † ₪ £ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Katherine Clifton, MD † Siteman Cancer Center at Barnes- Jewish Hospital and Washington University School of Medicine
Harvey Jay Cohen, MD † ₪ Duke Cancer Institute
Martine Extermann, MD, PhD † Moffitt Cancer Center
Cary P. Gross, MD Þ Yale Cancer Center/Smilow Cancer Hospital
Sumati Gupta, MD † Huntsman Cancer Institute at the University of Utah
Reshma Jagsi, MD, DPhil § University of Michigan Rogel Cancer Center
Aminah Jatoi, MD † Mayo Clinic Cancer Center
Nancy L. Keating, MD, MPH Þ Dana-Farber/Brigham and Women’s Cancer Center
Elizabeth Kessler, MD † University of Colorado Cancer Center
Thuy Koll, MD ₪ Fred & Pamela Buffett Cancer Center
Beatriz Korc-Grodzicki, MD, PhD ₪ Memorial Sloan Kettering Cancer Center
Mary Pat Lynch, DNP, RN £ ₪ Abramson Cancer Center at the University of Pennsylvania
June M. McKoy, MD, MBA, JD, MPH ₪ Þ Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Sumi Misra, MD Þ £ ₪ Vanderbilt-Ingram Cancer Center
Dominic Moon, MD § UT Southwestern Simmons Comprehensive Cancer Center
Tracey O’Connor, MD † Roswell Park Comprehensive Cancer Center
Cynthia Owusu, MD, MS ‡ Case Comprehensive Cancer Center/ University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Kavitha Ramchandran, MD † Stanford Cancer Institute
Ashley Rosko, MD ‡ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Marcia Russell, MD ¶ UCLA Jonsson Comprehensive Cancer Center
Christine Sam, MD ¶ Moffitt Cancer Center
Mina Sedrak, MD, MS † City of Hope National Medical Center
Fareeha Siddiqui, MD † ‡ UC San Diego Moores Cancer Center
Amy Stella, MD, ‡ University of Wisconsin Carbone Cancer Center
Derek L. Stirewalt, MD † ‡ Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Ishwaria M. Subbiah, MD, MS † £ The University of Texas MD Anderson Cancer Center
William P. Tew, MD † Þ Memorial Sloan Kettering Cancer Center
Grant R. Williams, MD, MSPH † ₪ O'Neal Comprehensive Cancer Center at UAB
NCCN Shaili Aggarwal, PhD Ryan Schonfeld, BA
4.临床试验(Clinical Trials):
NCCN认为任何癌症患者都可以在临床试验中得到最佳治疗,因此特别鼓励患者参与临床试验。 寻找NCCN成员组:https://www.nccn.org/home/member-institutions
5.NCCN对证据和共识分类( NCCN Categories of Evidence and Consensus):
推荐均为2A类,除非另有说明,请参见下表:
|
NCCN 对证据和共识的分类 |
1类 |
基于高水平证据,NCCN一致认为此项治疗合理 |
2A类 |
基于低水平证据,NCCN一致认为此项治疗合理 |
2B类 |
基于低水平证据,NCCN基本认为此项治疗合理 |
3类 |
基于任何水平证据,NCCN对此项治疗是否合理存在重大分歧 |
6.NCCN首选分类( NCCN Categories of Preference):
所有建议均视为合理,请参见下表:
|
NCCN 优先使用分类 |
首选干预方法 |
点赞 收藏 ![]() |